Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures
This study has been completed.
Study NCT00004817 Information provided by Office of Rare Diseases (ORD)
First Received: February 24, 2000 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Post-Traumatic Seizure Disorder
Head Injuries
Additional conditions recognized in this trial
Craniocerebral Trauma
Epilepsy
Epilepsy, Post-Traumatic
Seizures
More general conditions related to this trial
Brain Diseases
Brain Injuries
Central Nervous System Diseases
Disorders of Environmental Origin
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Trauma, Nervous System
Wounds and Injuries
Interventions listed in this trial
phenytoin
valproate sodium
Additional drug interventions recognized in this trial
Valproic Acid
More general drug interventions related to this trial
Anticonvulsants
Antimanic Agents
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
GABA Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Neurological Disorders and Stroke (NINDS)
Harborview Injury Prevention and Research Center
Back to top of Main Content
